Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 68,696 | 48,727 | 25,098 | 115,529 | 24,285 |
| Gross Profit | 68,696 | 48,727 | 25,098 | 115,529 | 24,285 |
| Operating Expenses | 94,858 | 92,463 | 87,406 | 154,905 | 134,113 |
| Operating Income | -26,162 | -43,736 | -62,308 | -39,376 | -109,828 |
| Interest Expense | 1,782 | 2,230 | 1,111 | 132 | 0 |
| Other Income | 35,111 | 3,439 | -9,490 | 8,906 | 822 |
| Pre-tax Income | 7,167 | -42,527 | -72,909 | -30,602 | -109,006 |
| Net Income Continuous | 7,167 | -42,527 | -72,909 | -30,602 | -109,006 |
| Net Income Discontinuous | N/A | -18,792 | -38,728 | N/A | N/A |
| Net Income | $7,167 | $-61,319 | $-111,637 | $-30,602 | $-109,006 |
| EPS Basic Total Ops | 1.05 | -15.96 | -38.10 | -15.62 | -62.76 |
| EPS Basic Continuous Ops | 1.05 | -11.07 | -24.88 | -15.66 | -62.91 |
| EPS Basic Discontinuous Ops | N/A | -4.89 | -13.22 | N/A | N/A |
| EPS Diluted Total Ops | 1.04 | -15.96 | -38.10 | -15.62 | -62.76 |
| EPS Diluted Continuous Ops | 1.04 | -11.07 | -24.88 | -15.66 | -62.91 |
| EPS Diluted Discontinuous Ops | N/A | -4.89 | -13.22 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -3.26 | -11.07 | -38.14 | -15.62 | -62.76 |
| EBITDA(a) | $-22,280 | $-35,996 | $-53,659 | $-29,192 | $-100,015 |